Evidence map›Paper›PMID 21471526›Full record

ArticleBlood2011

Protein disulfide isomerase blocks CEBPA translation and is up-regulated during the unfolded protein response in AML.

Simon Haefliger, Christiane Klebig, Kerstin Schaubitzer, Julian Schardt, Nikolai Timchenko, Beatrice U Mueller, Thomas Pabst

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Redox-Related Proteins in Melanoma Progression.Antioxidants (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Article
  10. ERO1-PDI Redox Signaling in Health and Disease.Antioxidants & redox signaling · 2021
    Review
  11. Article
  12. Syringin: A Phenylpropanoid Glycoside Compound inMolecules (Basel, Switzerland) · 2021
    Article
  13. Article
  14. Review
  15. Deletion ofFrontiers in cell and developmental biology · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Simon HaefligerDepartment of Medical Oncology, University Hospital and University of Berne, Berne, Switzerland.
Christiane Klebig
Kerstin Schaubitzer
Julian Schardt
Nikolai Timchenko
Beatrice U Mueller
Thomas Pabst
University Hospital of Bern · CHUniversity of Bern · CHBaylor College of Medicine · US

Funding

Molecular Mechanisms of C/EBP Alpha Mediated Growth ArrestR01GM055188 · NIGMS · CINCINNATI CHILDRENS HOSP MED CTR · PI TIMCHENKO, NIKOLAI A. · 1997 to 2013
$3.3M
Regulation of Cell Growth by RNA Binding ProteinsR01CA100070 · NCI · BAYLOR COLLEGE OF MEDICINE · PI TIMCHENKO, NIKOLAI A. · 2003 to 2012
$2.6M
NCI NIH HHS R01 CA100070NIGMS NIH HHS R01 GM055188
6 · The paper itself

Abstract

Deregulation of the myeloid key transcription factor CEBPA is a common event in acute myeloid leukemia (AML). We previously reported that the chaperone calreticulin is activated in subgroups of AML patients and that calreticulin binds to the stem loop region of the CEBPA mRNA, thereby blocking CEBPA translation. In this study, we screened for additional CEBPA mRNA binding proteins and we identified protein disulfide isomerase (PDI), an endoplasmic reticulum (ER) resident protein, to bind to the CEBPA mRNA stem loop region. We found that forced PDI expression in myeloid leukemic cells in fact blocked CEBPA translation, but not transcription, whereas abolishing PDI function restored CEBPA protein. In addition, PDI protein displayed direct physical interaction with calreticulin. Induction of ER stress in leukemic HL60 and U937 cells activated PDI expression, thereby decreasing CEBPA protein levels. Finally, leukemic cells from 25.4% of all AML patients displayed activation of the unfolded protein response as a marker for ER stress, and these patients also expressed significantly higher PDI levels. Our results indicate a novel role of PDI as a member of the ER stress-associated complex mediating blocked CEBPA translation and thereby suppressing myeloid differentiation in AML patients with activated unfolded protein response (UPR).

Indexed as

Gene Expression Regulation, LeukemicProtein BiosynthesisBlotting, WesternCalreticulinCCAAT-Enhancer-Binding ProteinsEndoplasmic ReticulumHL-60 CellsHumansImmunoprecipitationLeukemia, Myeloid, AcuteProtein Disulfide-IsomerasesReverse Transcriptase Polymerase Chain ReactionRNA, MessengerRNA, Small InterferingU937 CellsUnfolded Protein ResponseCalreticulinCCAAT-Enhancer-Binding ProteinsCEBPA protein, humanProtein Disulfide-IsomerasesRNA, MessengerRNA, Small Interfering

Identifiers

PMID21471526
PMCPMC3293752
OpenAlexW1975905680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.